A detailed history of Raleigh Capital Management Inc. transactions in Viatris Inc stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 180 shares of VTRS stock, worth $2,253. This represents 0.0% of its overall portfolio holdings.

Number of Shares
180
Previous 139 29.5%
Holding current value
$2,253
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$10.32 - $12.13 $423 - $497
41 Added 29.5%
180 $2,000
Q2 2024

Jul 31, 2024

SELL
$10.05 - $12.02 $854 - $1,021
-85 Reduced 37.95%
139 $1,000
Q1 2024

May 13, 2024

BUY
$11.27 - $13.53 $1,915 - $2,300
170 Added 314.81%
224 $2,000
Q4 2023

Feb 21, 2024

BUY
$8.77 - $10.85 $394 - $488
45 Added 500.0%
54 $0
Q2 2023

Jul 25, 2023

BUY
$9.02 - $10.29 $81 - $92
9 New
9 $0

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.